Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C07
ORGANIC CHEMISTRY
Load children
C07C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
Load children
235/00
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Load children Filter patents View analytics View as hierarchy Open in page
C07C235/02
having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
Load children Filter patents View analytics View as hierarchy Open in page
C07C235/04
the carbon skeleton being acyclic and saturated
Load children Filter patents View analytics View as hierarchy Open in page

C07C235/04

Process for the preparation of marimastat, marimastat prepared by this process, a pharmaceutical composition comprising the same, and uses thereof
20250214928 · 2025-07-03 ·

The invention relates to a process for the preparation of marimastat. The invention further relates to marimastat prepared by the process, and a pharmaceutical composition comprising said marimastat. The invention also relates to the pharmaceutical composition for use as a medicament, and said marimastat for use as a medicament. The invention further relates to the pharmaceutical composition for use in the prevention and treatment of diseases associated with hyperactivity of extracellular matrix metalloproteinases, and said marimastat for use in the prevention and treatment of diseases associated with hyperactivity of extracellular matrix metalloproteinases.

Process for the preparation of marimastat, marimastat prepared by this process, a pharmaceutical composition comprising the same, and uses thereof
20250214928 · 2025-07-03 ·

The invention relates to a process for the preparation of marimastat. The invention further relates to marimastat prepared by the process, and a pharmaceutical composition comprising said marimastat. The invention also relates to the pharmaceutical composition for use as a medicament, and said marimastat for use as a medicament. The invention further relates to the pharmaceutical composition for use in the prevention and treatment of diseases associated with hyperactivity of extracellular matrix metalloproteinases, and said marimastat for use in the prevention and treatment of diseases associated with hyperactivity of extracellular matrix metalloproteinases.